# The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients

> **NCT01948388** · PHASE4 · COMPLETED · sponsor: **Gaylis, Norman B., M.D.** · enrollment: 20 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** corticotrophin 80 units

## Key facts

- **NCT ID:** NCT01948388
- **Lead sponsor:** Gaylis, Norman B., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01948388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01948388, "The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01948388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*